Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Return on Equity (2016 - 2025)

Bio Key International's Return on Equity history spans 15 years, with the latest figure at 0.66% for Q3 2025.

  • For Q3 2025, Return on Equity fell 1212.0% year-over-year to 0.66%; the TTM value through Sep 2025 reached 0.66%, down 1212.0%, while the annual FY2024 figure was 1.78%, 90.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.66% at Bio Key International, down from 0.56% in the prior quarter.
  • Across five years, Return on Equity topped out at 24.54% in Q2 2024 and bottomed at 29.49% in Q4 2023.
  • The 5-year median for Return on Equity is 0.58% (2022), against an average of 2.46%.
  • The largest annual shift saw Return on Equity tumbled -2874bps in 2023 before it skyrocketed 4077bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.23% in 2021, then plummeted by -421bps to 1.22% in 2022, then tumbled by -2308bps to 29.49% in 2023, then surged by 93bps to 2.2% in 2024, then skyrocketed by 70bps to 0.66% in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Return on Equity are 0.66% (Q3 2025), 0.56% (Q2 2025), and 0.8% (Q1 2025).